About Easton Capital Investment Group
Easton Capital Investment Group is a venture capital firm founded in 1999. It is primarily based out of New York City, United States. As of Jun 2025, Easton Capital Investment Group is an active investor, having invested in 45 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Seed round of HyperFlex Overall, Easton Capital Investment Group portfolio has seen 5 IPOs and 17 acquisitions including key companies like Bluebird Bio, ElectroCore and Acorda. A lot of funds co-invest with Easton Capital Investment Group, with names like Morgenthaler sharing a substantial percentage of its portfolio. Easton Capital Investment Group has team of 7 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 5 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Easton Capital Investment Group's List of Top Investments
Easton Capital Investment Group has a portfolio of 45 companies. Their most notable investments are in Within3 and Achronix.Their portfolio spans across United States, Israel and South Africa. They have invested in Life Sciences, Enterprise Applications, HealthTech and 6 other sectors, across stages such as Series A, Series B and 5 more. Here is the list of top investments by Easton Capital Investment Group:1. Bluebird Bio
Developer of gene therapies for severe genetic and rare diseases. The company's products include Lenti-D for Childhood Cerebral Adrenoleukodystrophy (ALD) and LentiGlobin for rare hemoglobinopathies. The company's other products for multiple myeloma and HPV-associated cancer are in the preclinical stage. The company is also using homing endonuclease and megaTAL gene-editing technologies in a variety of potential applications and disease areas, including hematology and oncology.
Key facts about Bluebird Bio
- Founded Year: 1992
- Location: Cambridge (United States)
- Annual Revenue: $83.8M as on Dec 31, 2024
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $136M
- Employee Count: 331 as on Mar 31, 2026
- Investors: RA Capital Management, Sanofi Ventures and 9 Others
- Latest Funding Round: Post IPO, Jun 03, 2022, $*****
- Highlight: Acquired
2. TigerConnect
Provider of a cloud-based collaboration and communication platform for healthcare professionals. The platform offers features to improve communication networks between patients, providers in hospitals, and healthcare organizations using video, voice, or text. The real-time HIPAA-compliant centralized platform provides secure messaging, EHR integration of the patients, notifications, and reminders for hospitals and care teams. The products of the company are TigerText Essentials, TigerFlow+, TigerTouc+, and TigerFlow Enterprise.
Key facts about TigerConnect
- Founded Year: 2010
- Location: Santa Monica (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $426M
- Employee Count: 344 as on Mar 31, 2026
- Investors: Section Partners, Industry Ventures and 19 Others
- Latest Funding Round: Series E, Jan 10, 2022, $*****
- Highlight: Editors' Pick
3. ElectroCore
Developer of non-invasive vagus nerve stimulation devices. The company has developed gammaCore a hand-held portable device that produces a mild electrical signal to treat migraines and cluster headaches. It is also, used for epilepsy, gastric motility disorders, depression, and anxiety.
Key facts about ElectroCore
- Founded Year: 2005
- Location: Basking Ridge (United States)
- Annual Revenue: $25.2M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $161M
- Employee Count: 97 as on Mar 31, 2026
- Investors: avenuealtd.com, Core Ventures Group and 6 Others
- Latest Funding Round: Post IPO, Oct 02, 2025, $*****
- Highlight: Public
4. Acorda
Developer of therapies that restore neurological function. The company is engaged in the development and commercialization of therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's product include Ampyra (dalfampridine) Extended Release Tablets (Ampyra), as a treatment to improve walking in patients with MS.
Key facts about Acorda
- Founded Year: 1995
- Location: Ardsley (United States)
- Annual Revenue: $119M as on Dec 31, 2022
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $66.5M
- Employee Count: 109 as on Dec 31, 2022
- Investors: Saints Capital, Ridgeback Capital Management and 15 Others
- Latest Funding Round: Grant (prize money), Sep 30, 2011, $*****
- Highlight: Acquired
5. HYBE
Key facts about HYBE
- Founded Year: 2020
- Location: Seoul (South Korea)
- Stage: Public
- Employee Count: 201 - 500 as on Jul 01, 2024
- Investors: Shinhan Venture Investment, IMM Investment and 9 Others
- Latest Funding Round: Post IPO, Aug 06, 2024, $*****
- Highlight: Public
Easton Capital Investment Group's Year-on-Year Investment Trends
Easton Capital Investment Group has invested in 45 companies over the last 24 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in HyperFlex and most recent follow-on round was in Claret Medical.Easton Capital Investment Group's Investments by Stage
Easton Capital Investment Group has made 14 investments in Series A stage with an average round size of $11.7M, 7 investments in Series B stage with an average round size of $18.2M and 6 investments in Series C stage with an average round size of $35.1M.Stage of entry | No. of Investments |
|---|---|
Series A | 14 |
Series B | 7 |
Series C | 6 |
Series E | 4 |
Post IPO | 2 |
Others | 4 |
Note: We have considered here, only first round of investments
Easton Capital Investment Group's Investments by Sector
Easton Capital Investment Group has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Vertical SaaS. Notably, it has invested in 39 Tech companies, 33 Enterprise (B2B) companies, 22 Software companies and at least 10 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 26 |
Enterprise Applications | 11 |
HealthTech | 8 |
High Tech | 5 |
Vertical SaaS | 4 |
Others | 11 |
Note: We have considered here, only first round of investments
Easton Capital Investment Group's Investments by Geography
Easton Capital Investment Group has made most investments in United States (36), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 36 |
Canada | 1 |
South Africa | 1 |
Note: We have considered here, only first round of investments
Easton Capital Investment Group's recent investments
Easton Capital Investment Group has not made any investment in 2026 so far.Here are the most recent investments by Easton Capital Investment Group:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 10, 2025 | United States | Seed | 6948 | - | |
Oct 19, 2017 | United States | Series C | 7877 | [+3] | |
Aug 05, 2015 | United States | Series A | 7173 | [+1] | |
Jun 25, 2015 | United States | Series B | 5425 | [+2] | |
Aug 21, 2014 | United States | Series B | 4559 | [+1] |
IPOs and Publicly Listed companies in Easton Capital Investment Group's Portfolio
5 of Easton Capital Investment Group's portfolio companies have become public. HYBE got listed on the Korea Exchange (KRX), in Oct 2020 at marketcap of $3.99B and ElectroCore got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $78M.Here are Easton Capital Investment Group's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 15, 2020 | - | - | 6474 | |
Jun 22, 2018 | Jul 01, 2014 | Series B | 8968 | |
Apr 13, 2006 | Dec 05, 2002 | Series A | 6625 | |
Nov 09, 2005 | Mar 10, 2004 | Series C | 4896 | |
Nov 09, 2005 | Mar 10, 2004 | Series B | 7963 |
Acquired companies in Easton Capital Investment Group's Portfolio
17 companies from Easton Capital Investment Group's portfolio have been acquired. The most recent acquisition were Assertio in Apr 2026 by Garda Therapeutics for $125M.Here are Easton Capital Investment Group's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 08, 2026 | Apr 22, 2003 | Post IPO | 3685 | |
Feb 21, 2025 | Oct 04, 2004 | Series A | 3641 | |
May 15, 2024 | May 09, 2003 | Series C | 4149 | |
Oct 24, 2023 | Apr 05, 2007 | Series D | 8077 | |
Feb 08, 2023 | Jul 31, 2006 | Post IPO | 8824 |
Team profile of Easton Capital Investment Group
Easton Capital Investment Group has a team of 7 members including 5 Partners located in United States. Easton Capital Investment Group's team does not sit on the board of any company as of now.Here is a list of all team members in Easton Capital Investment Group:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Califon | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | New York City | - | ||
Partner | Marina | - |
Co-investors of Easton Capital Investment Group
Over the past 24 years, 228 investors have co-invested in Easton Capital Investment Group's portfolio companies. This includes funds and angels.
- Invested before Easton Capital Investment Group: Johnson & Johnson Innovation – JJDC, Alta Partners and 61 others have invested in rounds before Easton Capital Investment Group. There are 2 companies where Johnson & Johnson Innovation – JJDC has invested before Easton Capital Investment Group and 2 companies where Alta Partners has invested before Easton Capital Investment Group.
- Top Co-investors of Easton Capital Investment Group: 84 investors entered a company along with Easton Capital Investment Group. These include investors like Morgenthaler (4 companies).
- Invested after Easton Capital Investment Group: A total of 81 investors have invested in Easton Capital Investment Group's portfolio after their investments. Top Investors include HHS (3 companies), Orbimed (2 companies) and Montreux Equity Partners (2 companies).
Recent News related to Easton Capital Investment Group
•
•
Keyavi Data Appoints Board of Directors and Advisory BoardBusiness Wire•Jun 10, 2021•Keyavi Data, PharmaJet, Vonzos Partners, Easton Capital Investment Group and 2 others
•
•
•
Wildflower Health's new $5M will help it expand beyond pregnancy apps | MobiHealthNewsMobiHealthNews•Jun 29, 2015•Wildflower Health, Easton Capital Investment Group, HealthTech Capital, Cambia Health Solutions and 1 other
•
•
Google Acquires Facebook Marketing Startup Toro – TechCrunchTechCrunch+•Feb 24, 2015•Red Hot Labs, Google, Toro, IGA Worldwide and 3 others
•
•
•
